跳至主要内容
临床试验/ITMCTR2200006555
ITMCTR2200006555尚未招募1 期

Study to Evaluate the Effect of Qingre Shuji Decoction combined with Guideline-Directed Medical Treatment on the Quality of Life and Clinical Outcomes in Patients with ankylosing spondylitis&#32

China-Japan Friendship Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • ?18–75 years old ;
  • ?Patients met the diagnostic criteria of Western medicine and disease activity, and the VAS score of spinal pain (the second item of BASDAI) was = 40 mm.
  • ?Patients who met the diagnostic criteria of kidney deficiency and dampness-heat syndrome in TCM ;
  • ?voluntary signing of informed consent ;
  • ?Drug cleaning : SASP, methotrexate (MTX), leflunomide (LEF) and other antirheumatic drugs, hormones, biological agents or small molecule targeted drugs were not used more than 1 month before randomization.

排除标准

  • ?pregnant or lactating women and mental patients with severe malnutrition or severe damage to the heart, brain, kidney and hematopoietic system ;
  • ?patients with other rheumatic diseases ;
  • ?Patients with severe spinal and hip joint dysfunction who needed surgery during this study ;
  • ?Concurrent NSAIDs use contraindications ;
  • ?contraindications for combined use of biological agents.

研究者

发起方
China-Japan Friendship Hospital

相似试验